<?xml version='1.0'?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:georss="http://www.georss.org/georss" xmlns:atom="http://www.w3.org/2005/Atom" >
<channel>
	<title><![CDATA[BOL: Related items]]></title>
	<link>https://bioinformaticsonline.com/related/36635?offset=350</link>
	<atom:link href="https://bioinformaticsonline.com/related/36635?offset=350" rel="self" type="application/rss+xml" />
	<description><![CDATA[]]></description>
	
	<item>
	<guid isPermaLink="true">https://bioinformaticsonline.com/bookmarks/view/10243/new-rna-seq-tool</guid>
	<pubDate>Fri, 25 Apr 2014 10:59:04 -0500</pubDate>
	<link>https://bioinformaticsonline.com/bookmarks/view/10243/new-rna-seq-tool</link>
	<title><![CDATA[New RNA Seq tool]]></title>
	<description><![CDATA[<p>"<span>By removing the time-consuming step of read mapping, the authors reported, Sailfish able to provide quantification estimates 20&ndash;30 times faster than current methods without loss of accuracy."</span></p>
<p><span>Tool link:</span></p>
<p><span>http://www.cs.cmu.edu/~ckingsf/software/sailfish/</span></p>
<p><span></span></p><p>Address of the bookmark: <a href="http://www.genengnews.com/gen-news-highlights/lightweight-algorithms-sail-through-rna-sequencing-data/81249765/" rel="nofollow">http://www.genengnews.com/gen-news-highlights/lightweight-algorithms-sail-through-rna-sequencing-data/81249765/</a></p>]]></description>
	<dc:creator>Rahul Agarwal</dc:creator>
</item>
<item>
	<guid isPermaLink="true">https://bioinformaticsonline.com/news/view/10966/genxpro-gmbh</guid>
	<pubDate>Thu, 22 May 2014 07:18:35 -0500</pubDate>
	<link>https://bioinformaticsonline.com/news/view/10966/genxpro-gmbh</link>
	<title><![CDATA[GenXPro GmbH]]></title>
	<description><![CDATA[<p><strong>GenXPro</strong>&nbsp;GMbH is service provider for entire spectrum of nucleotide-based information&nbsp;of any biological sample. By combining intelligent data reduction techniques and&nbsp;latest next generation sequencing technologies, our service portfolio provides most accurate and cost efficient solutions for&nbsp;transcriptomic-, genomic- or epigenomic research.</p><p><span><span><strong><span>GENXPRO GMBH</span>,&nbsp;</strong></span></span><span>ALTENH&Ouml;FERALLEE 3,&nbsp;</span><span>60438 FRANKFURT MAIN,&nbsp;</span><span>GERMANY</span></p><p><span><span><strong>Website</strong></span>:&nbsp;<a href="http://www.genxpro.info/products_and_services/"></a><a href="http://www.genxpro.info/products_and_services/">http://www.genxpro.info/products_and_services/</a></span></p><p><span><strong>PHONE</strong>: +49 (0)69- 95 73 97 10,&nbsp;FAX: +49 (0)69- 95 73 97 06</span></p><p><span>EMAIL: info@genxpro.de</span></p>]]></description>
	<dc:creator>Rahul Agarwal</dc:creator>
</item>
<item>
	<guid isPermaLink="true">https://bioinformaticsonline.com/file/view/13415/genomics-and-sequencing-approach-for-identification-of-biomarkers-to-assess-the-efficacy-of-tgf-%CE%B2ri-inhibitors-of-liver-cancer-in-vivo</guid>
	<pubDate>Tue, 05 Aug 2014 13:55:32 -0500</pubDate>
	<link>https://bioinformaticsonline.com/file/view/13415/genomics-and-sequencing-approach-for-identification-of-biomarkers-to-assess-the-efficacy-of-tgf-%CE%B2ri-inhibitors-of-liver-cancer-in-vivo</link>
	<title><![CDATA[Genomics and sequencing approach for identification of biomarkers to assess the efficacy of TGF-βRI inhibitors (of liver cancer) in vivo]]></title>
	<description><![CDATA[<p>Liver cancer is third leading cause of deaths and fourth most frequent occuring cancer worldwide. There are multiple signaling pathways responsible for causing cancer amongst which TGFb is most important cytokine whose signaling pathway promote cancer. However, main problem is to cure this cancer at late stage where we still have no treatment strategy to tackle this deadly cancer. &nbsp;Hence we need to find out new therapeutic target. One way is to look the relationships between mRNA, methylation and miRNA data of patients with different pathological conditions (cancer vs control either with inhibitor/not). MiRNA is small RNA molecules known to inhibit mRNA expression of particular gene by binding improperly to 3'UTR region of a gene and hence block binding of TF /translation of gene. CpG regions is known to located at promoter region of gene (5' UTR) and usually hypomethylated which allow to gene to transcribe and translate however sometime this region become hyper-methylated thats prevent expression of host gene. Thus , integration of these three data reveal new targets and pathways important for causing or preventing cancer and also reveal biomarker thats check the effects of inhibitor on signaling pathway underlying liver cancer.</p>]]></description>
	<dc:creator>Rahul Agarwal</dc:creator>
	<enclosure url="https://bioinformaticsonline.com/file/download/13415" length="26423" type="image/jpeg" />
</item>
<item>
	<guid isPermaLink="true">https://bioinformaticsonline.com/blog/view/29407/live-webinar-on-rna-seq-data-analysis-on-9-nov-2016</guid>
	<pubDate>Wed, 19 Oct 2016 05:25:27 -0500</pubDate>
	<link>https://bioinformaticsonline.com/blog/view/29407/live-webinar-on-rna-seq-data-analysis-on-9-nov-2016</link>
	<title><![CDATA[Live Webinar on RNA-Seq Data Analysis on 9 Nov 2016]]></title>
	<description><![CDATA[<p><strong><a href="http://www.strand-ngs.com/webinar_registration">Live Webinar on RNA-Seq Data Analysis</a></strong></p><p><a href="http://www.strand-ngs.com/webinar_registration">Abstract: </a>Strand NGS supports an extensive workflow for the analysis and visualization of RNA-Seq data. The workflow includes Transcriptome / Genome alignment, Differential expression analysis with Statistical approach and Splicing events detection. Strand NGS also supports novel discovery like identification of novel genes, exons and Novel splice junctions, alongside it can also detect gene fusion events. Further downstream analysis such as GO and pathway analysis can be performed on the set of interesting genes. The product has an option to create pipelines for time consuming jobs which automates analysis and leaves more time for end data interpretation. This webinar will give an overview of the features in the RNA-Seq data analysis workflow in Strand NGS and also highlights on parameters within each feature that can be optimized depending on datasets and analysis needs.</p><p><a href="http://www.strand-ngs.com/webinar_registration">Speaker:</a> Mr. Sugandan Sivamani, Senior Application Scientist, Strand Life Sciences</p><p>Date: 9th Nov, <a href="http://www.strand-ngs.com/webinar_registration">Session 1</a> for SAPK/ APFO: 2:30 PM IST Date: 9th Nov, <a href="http://www.strand-ngs.com/webinar_registration">Session 2</a> for AFO/ EMEA: 9:00 AM PST</p><p>Register here <a href="http://www.strand-ngs.com/webinar_registration">http://www.strand-ngs.com/webinar_registration</a></p>]]></description>
	<dc:creator>Strand</dc:creator>
</item>
<item>
	<guid isPermaLink="true">https://bioinformaticsonline.com/bookmarks/view/39875/lrsday-long-read-sequencing-data-analysis-for-yeasts</guid>
	<pubDate>Mon, 26 Aug 2019 18:07:33 -0500</pubDate>
	<link>https://bioinformaticsonline.com/bookmarks/view/39875/lrsday-long-read-sequencing-data-analysis-for-yeasts</link>
	<title><![CDATA[LRSDAY: Long-read Sequencing Data Analysis for Yeasts]]></title>
	<description><![CDATA[<p><span>Long-read sequencing technologies have become increasingly popular in genome projects due to their strengths in resolving complex genomic regions. As a leading model organism with small genome size and great biotechnological importance, the budding yeast,&nbsp;</span><em>Saccharomyces cerevisiae</em><span>, has many isolates currently being sequenced with long reads.&nbsp;</span></p><p>Address of the bookmark: <a href="https://github.com/yjx1217/LRSDAY" rel="nofollow">https://github.com/yjx1217/LRSDAY</a></p>]]></description>
	<dc:creator>Poonam Mahapatra</dc:creator>
</item>
<item>
	<guid isPermaLink="true">https://bioinformaticsonline.com/bookmarks/view/43892/choosing-the-right-ngs-sequencing-instrument-for-your-study</guid>
	<pubDate>Wed, 15 Jun 2022 00:37:29 -0500</pubDate>
	<link>https://bioinformaticsonline.com/bookmarks/view/43892/choosing-the-right-ngs-sequencing-instrument-for-your-study</link>
	<title><![CDATA[Choosing the Right NGS Sequencing Instrument for Your Study]]></title>
	<description><![CDATA[<p>The right sequencing instrument for your study depends on your project goal. Setting aside turnaround time and price, it essentially comes down to the numbers of reads and read length you need for your experiment. Below, we've described and compared metrics for each of the instruments available. If you&rsquo;re new to high-throughput sequencing and have questions about how you should design your sequencing run, fill out our&nbsp;<a href="https://genohub.com/ngs-consultation/"><span>free consultation form</span></a>&nbsp;and we'll get in touch with you to help.</p>
<p>More at&nbsp;https://genohub.com/ngs-instrument-guide/</p><p>Address of the bookmark: <a href="https://genohub.com/ngs-instrument-guide/" rel="nofollow">https://genohub.com/ngs-instrument-guide/</a></p>]]></description>
	<dc:creator>Neel</dc:creator>
</item>
<item>
	<guid isPermaLink="true">https://bioinformaticsonline.com/view/1906</guid>
	<pubDate>Sun, 11 Aug 2013 11:13:58 -0500</pubDate>
	<link>https://bioinformaticsonline.com/view/1906</link>
	<title><![CDATA[Compressive Genomics]]></title>
	<description><![CDATA[<p>The key to finding a solution is to notice that most&nbsp;<a href="http://www.i-programmer.info/news/181-algorithms/4537-a-new-dna-sequence-search-compressive-genomics.html">genomic</a>sequences differ by very little. It may well be that the number of complete genome sequences being stored is increasing rapidly, but the actual amount of new data is very small. In other words, a single DNA sequence isn't particularly compressible but a set of sequences shares so much in common that the redundancy can be used to store them in a much smaller storage space. (Source:e-article from&nbsp;Alex Armstrong)</p><p><a href="http://www.i-programmer.info/news/181-algorithms/4537-a-new-dna-sequence-search-compressive-genomics.html">http://www.i-programmer.info/news/181-algorithms/4537-a-new-dna-sequence-search-compressive-genomics.html</a></p><p><a href="http://en.wikipedia.org/wiki/Compression_of_Genomic_Re-Sequencing_Data">http://en.wikipedia.org/wiki/Compression_of_Genomic_Re-Sequencing_Data</a></p><p><a href="http://www.nature.com/nbt/journal/v30/n7/full/nbt.2241.html">http://www.nature.com/nbt/journal/v30/n7/full/nbt.2241.html</a></p><p><a href="http://bioinformatics.oxfordjournals.org/content/29/13/i283.full">http://bioinformatics.oxfordjournals.org/content/29/13/i283.full</a></p><p><a href="http://groups.csail.mit.edu/cb/cast/">http://groups.csail.mit.edu/cb/cast/</a></p>]]></description>
	<dc:creator>Rahul Agarwal</dc:creator>
</item>
<item>
	<guid isPermaLink="true">https://bioinformaticsonline.com/bookmarks/view/3885/precision-medicine</guid>
	<pubDate>Sat, 24 Aug 2013 15:47:03 -0500</pubDate>
	<link>https://bioinformaticsonline.com/bookmarks/view/3885/precision-medicine</link>
	<title><![CDATA[Precision Medicine]]></title>
	<description><![CDATA[<p>Coupling established clinical&ndash;pathological indexes with state-of-the-art molecular profiling to create diagnostic, prognostic, and therapeutic strategies precisely tailored to each patient's requirements &mdash; hence the term &ldquo;Precision medicine&rdquo;&nbsp;</p>
<p>Source:<a href="http://www.nejm.org/doi/full/10.1056/NEJMp1114866">http://www.nejm.org/doi/full/10.1056/NEJMp1114866</a></p>
<p><strong>Another video on precision medicine</strong>:</p>
<p><a href="http://www.youtube.com/watch?v=Pi8W0yOXnzE">http://www.youtube.com/watch?v=Pi8W0yOXnzE</a></p>
<p>Precision Medicine basically intergrates bioinformatics, genomics , genetics, molecular biology and nanotechnology to deliver precise cure/diagnotics to a specific patient.</p>
<p>Examples:</p>
<ul>
<li><span>The drug imatinib (Gleevec) designed to inhibit an altered enzyme produced by a fused version of two genes found in chronic myelogenous leukemia.</span></li>
<li><span>The breast cancer drug trastuzumab (Herceptin) works only for women whose tumors have a particular genetic profile called HER-2 positive.</span></li>
</ul>
<p><span>E.g. source :</span></p>
<p><span><a href="http://www.bionews-tx.com/news/2013/08/15/how-the-impact-of-cancer-genomics-on-precision-medicine-is-revolutionizing-cancer-treatment/">http://www.bionews-tx.com/news/2013/08/15/how-the-impact-of-cancer-genomics-on-precision-medicine-is-revolutionizing-cancer-treatment/</a></span></p><p>Address of the bookmark: <a href="http://www.cbsnews.com/video/watch/?id=50149783n" rel="nofollow">http://www.cbsnews.com/video/watch/?id=50149783n</a></p>]]></description>
	<dc:creator>Rahul Agarwal</dc:creator>
</item>
<item>
	<guid isPermaLink="true">https://bioinformaticsonline.com/bookmarks/view/3029/bioinformatics-market-in-india</guid>
	<pubDate>Fri, 23 Aug 2013 07:08:49 -0500</pubDate>
	<link>https://bioinformaticsonline.com/bookmarks/view/3029/bioinformatics-market-in-india</link>
	<title><![CDATA[Bioinformatics market in India]]></title>
	<description><![CDATA[<div><strong>Key Topics Covered in the Report:</strong></div>
<ul>
<li>The market size of the Indian Bioinformatics Industry , FY&rsquo;2007-FY&rsquo;2013</li>
<li>Market segmentation of India bioinformatics industry by application by sectors, FY&rsquo;2007-FY&rsquo;2013</li>
<li>Market Segmentation of India bioinformatics industry by products and services,FY&rsquo;2007-FY&rsquo;2013</li>
<li>Market Segmentation of India bioinformatics industry by applications of bioinformatics ,FY&rsquo;2007-FY&rsquo;2013</li>
<li>India bioinformatics industry trends and developments</li>
<li>Government regulations and initiatives of India bioinformatics industry</li>
<li>Major bioinformatics research institutes in India</li>
<li>Market Share of leading players in bioinformatics industry in India,FY&rsquo;2013</li>
<li>Company profiles of major players in India bioinformatics industry</li>
<li>Future outlook and projections on the basis of revenue in India bioinformatics market, FY&rsquo;2014-FY&rsquo;2018</li>
</ul>
<p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;(Source: Ken Research)</p><p>Address of the bookmark: <a href="http://www.kenresearch.com/healthcare/biotechnology/india-bioinformatics-industry-research-report/392-91.html" rel="nofollow">http://www.kenresearch.com/healthcare/biotechnology/india-bioinformatics-industry-research-report/392-91.html</a></p>]]></description>
	<dc:creator>Rahul Agarwal</dc:creator>
</item>

<item>
  <guid isPermaLink='true'>https://bioinformaticsonline.com/researchlabs/view/4591/the-breitbart-lab</guid>
  <pubDate>Tue, 17 Sep 2013 18:19:49 -0500</pubDate>
  <link></link>
  <title><![CDATA[The Breitbart lab]]></title>
  <description><![CDATA[
<p>Breitbart’s lab has created a new branch of biology called metagenomics in which one can sample and sequence genetic material collected from the environment.</p>

<p>Breitbart lab is located in the College of Marine Science at the University of South Florida. She is chosen as top "10 Brilliant" scientist by Popular Science magazine.<br />http://www.popsci.com/science/article/2013-09/mya-breitbart</p>

<p>Lab Link:<br />https://sites.google.com/site/breitbartgenomicslab/<br />http://www.marine.usf.edu/faculty/mya-breitbart.shtml</p>
]]></description>
</item>

</channel>
</rss>